This contract will involve developing a landscape assessment of evidentiary standards and developing evidentiary standards for the use of pharmacodynamic biomarkers for biosimilar drug development.
Ended Awarded Last action
- Contract number
- 75F40119F19001
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $5,638,828
Award facts
- Opportunity
-
- TFTPMC000874B Solicitation number
- Contract value 100% obligated
- $5,638,827.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20903, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$8,536 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,534,658 | |
| Supplemental Agreement for work within scope | $1,701,713 | |
| Other Administrative Action | $330,989 | |
| Other Administrative Action | $668,064 | |
| Other Administrative Action | $1,500 | |
| Supplemental Agreement for work within scope | $278,016 | |
| Original award | $1,132,424 |
About this award
This federal contract was awarded by the Food and Drug Administration (FDA) to Booz Allen Hamilton Inc. for $5,638,827.56 to develop a landscape assessment of evidentiary standards and establish evidentiary standards for the use of pharmacodynamic biomarkers in biosimilar drug development. The contract is a call under Booz Allen Hamilton's Mission Oriented Business Integrated Services (MOBIS) Blanket Purchase Agreement (BPA) with the FDA, which provides organizational change management and business modernization support services.
The contract has no set-aside designation, and Booz Allen Hamilton Inc. is the prime contractor. This award builds on Booz Allen Hamilton's extensive experience providing a wide range of services to various federal agencies, including the Department of Defense, Department of Energy, and NASA. The parent company, Booz Allen Hamilton Holding Corporation, has a long history of supporting critical government initiatives across defense, intelligence, and civilian markets through both contract and grant awards.
Quick answers
Who was awarded contract 75F40119F19001?
75F40119F19001 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on January 8, 2019.
How much is contract 75F40119F19001 worth?
The government has obligated $5,638,828 on 75F40119F19001.
Is contract 75F40119F19001 an order under another contract?
Yes. 75F40119F19001 is a BPA call under GS23F9755H-HHSF223201510027B, a blanket purchase agreement, on Mission Oriented Business Integrated Services (MOBIS).
Was contract 75F40119F19001 competed?
The extent of competition for 75F40119F19001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award